Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy.

@article{Robinson2007TargetedTU,
  title={Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy.},
  author={Alice A Robinson and W. J. Watson and Kimberly K. Leslie},
  journal={The Lancet. Oncology},
  year={2007},
  volume={8 8},
  pages={738-43}
}
An expanding knowledge of the signalling pathways involved in the cell cycle has led to great improvements in the understanding of the molecular events involved in carcinogenesis. The past decade has seen substantial advances with the introduction of several classes of targeted therapeutics for the treatment of various cancers and autoimmune disorders. However, the question arises as to whether pregnant women can take advantage of these new treatments in view of the potential risks to the fetus… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…